血糖反応の予測による個別化された栄養
David Zeevi1, Tal Korem1, Niv Zmora2
1Department of Computer Science and Applied Mathematics, Weizmann Institute of Science, Rehovot 7610001, Israel; Department of Molecular Cell Biology, Weizmann Institute of Science, Rehovot 7610001, Israel.
Cell
|November 23, 2015
まとめ
機械学習による パーソナライズされた栄養プランは 血糖の急上昇を効果的に管理できます このアプローチは,食後のグルコースレベルを制御するための一般的な食事アドバイスよりも有望です.
科学分野:
- 代謝 健康
- 栄養学
- パーソナライズ された 医療
背景:
- 食事後の血糖値上昇は世界的な健康問題であり,前糖尿病とII型糖尿病のリスクを高めています.
- 現在のグルコース管理のダイエット戦略は,食事に対する個々の反応の変動が大きいため,有効性が限られている.
研究 の 目的:
- 同じ食事に対する食後の血糖反応の変動性を調べる.
- パーソナライズされた食後の血糖反応を予測するための機械学習アルゴリズムの開発と検証.
- アルゴリズムに基づいて個別化された食事介入の有効性を評価する.
主な方法:
- 継続的なグルコースモニタリング 800人のコホートで,46,898回の食事に対する反応を分析した.
- 血液のパラメータ,食事,人体測定,身体活動,腸内微生物群を統合した機械学習アルゴリズムの開発
- 独立したコホートでの検証と,盲検されたランダム化された制御された食事介入.
主要な成果:
- 同様の食事に対する血糖値の有意な変動が観察され,普遍的な食事の推奨事項に疑問を呈した.
- 機械学習アルゴリズムは 個別化された食後の血糖反応を正確に予測しました
- 個別化された食事の介入により,食後のグルコース濃度が著しく低下し,腸内微生物群が変化しました.
結論:
- 機械学習によるパーソナライズされた食事のアプローチは,食後の高血糖症を効果的に管理することができます.
- この戦略は,高血糖に関連した代謝結果を緩和する有望な手段です.
関連する概念動画
Pharmacogenomics: Identification of New Drug Targets
76
Advances in genomics have profoundly influenced drug discovery by increasing both the speed and accuracy of pharmaceutical development. Pharmacogenomics, which examines how genetic variation influences drug response, facilitates the identification of novel therapeutic targets and enables patient stratification for personalized treatment. These strategies contribute to improved drug efficacy, minimized adverse effects, and more efficient clinical trial design.Mapping genetic differences...
76
Hypoglycemia and Glucagon
1.3K
Without prolonged fasting, healthy individuals maintain blood glucose levels above 3.5 mM due to a well-adapted neuroendocrine counterregulatory system that effectively prevents acute hypoglycemia, a potentially life-threatening condition. The primary clinical scenarios for hypoglycemia encompass diabetes treatment, inappropriate production of endogenous insulin or insulin-like substances by tumors, and the use of glucose-lowering agents in non-diabetic individuals. Notably, hypoglycemia in the...
1.3K
Hormones Regulating Blood Glucose
8.4K
Insulin is released by beta cells of the pancreas when blood glucose levels are high. It facilitates glucose absorption and utilization in insulin-dependent cells with insulin receptors on their plasma membranes. Insulin promotes glucose uptake by increasing the number of glucose transport proteins in the cell membrane, allowing glucose to enter the cell. As a result, glucose utilization and ATP production are enhanced.
In addition to accelerating glucose uptake and utilization, insulin has...
In addition to accelerating glucose uptake and utilization, insulin has...
8.4K
Pharmacogenetics and Pharmacogenomics: Overview
144
Pharmacogenetics and pharmacogenomics examine how genetic factors influence an individual's response to drugs. While pharmacogenetics focuses on the impact of specific genetic variants on drug effects, pharmacogenomics takes a broader approach, studying how genetic variation across populations contributes to differences in drug responses. These fields aim to explain why individuals may experience varying levels of efficacy or adverse reactions to the same medication.Variability in drug...
144
Diabetes Mellitus: Type 2 and Gestational
5.5K
Type 2 diabetes, characterized by insulin resistance, arises when the insulin receptors on cells lose responsiveness to insulin, diminishing the cell's capacity to take up glucose, resulting in elevated blood glucose levels. To receive a diagnosis of Type 2 diabetes, a series of blood glucose tests are necessary to assess whether the blood glucose falls within normal parameters. If the result is out of the normal range, a patient may be diagnosed as prediabetic or diabetic, depending on the...
5.5K
Combination Therapies and Personalized Medicine
6.3K
Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
6.3K


